Still Has A Pulse It was nice to see a slight uptick today. Unfortunately the news is not yet positive on the covid front, especially as one can look to the future in NA by observing Asia and Europe ....but that spells good news for AcuVid should final submission and FDA approval be imminent.
Quite frankly there needs to be another update and soon as it can't possibly take this long to put the final submission together ...no matter how detailed the report needs to be.
Fair Value, overvalued and undervalued share valuations by Morningstar of $.33, $.76 and $.14 respectively, suggest the stock is rising from the bottom. Maybe the slight rise today is another indication of that. Certainly the stock is much closer to oversold than overbought.
Any day now???